Taiwan - Delayed Quote TWD

Apex Biotechnology Corp. (1733.TW)

Compare
29.95
0.00
(0.00%)
At close: 1:30:29 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Dr. Thomas Y. S. Shen Ph.D. Chairman, CEO & GM -- -- --
James Chu Chief Financial Officer -- -- --
Chun Hui Wu Vice President of Administration & Spokesman -- -- --
Ben Shen Vice President of Marketing & Sales -- -- --
Meng Wen Yang Vice GM, VP of Manufacturing & Director -- -- --

Apex Biotechnology Corp.

No. 7, Li-Hsin 5th Road
Hsinchu Science Park
Hsinchu City, 30078
Taiwan
886 3 564 1952 https://www.apexbio.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemoglobin screening systems. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.

Corporate Governance

Apex Biotechnology Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 17, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers